We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Event

Webinar on Assurances: What are they, Why and When do I need them

The Federal wide Assurance is required for NIH funded studies. It is a written assurance filed with the Office for Human Research Protections (OHRP) that outlines under which terms a study will be reviewed, approved, and conducted.

Overview: The Federal wide Assurance is required for NIH funded studies. It is a written assurance filed with the Office for Human Research Protections (OHRP) that outlines under which terms a study will be reviewed, approved, and conducted. This document, signed by the Institutional Official, sets forth certain requirements that must be upheld by an institution who has filed such an agreement. One of the terms deals with written agreements for non-affiliated investigators and institutions.When a researcher "engages" a site or individual not currently governed by his/her home institution, the researcher has the option of asking the non-affiliated site or individual to obtain a separate IRB approval or to request that his home institutional review board become the IRB of Record. Once this request is made, the potential IRB of Record must gather certain information and require certain written agreements in order to become the IRB of Record. More often than not, when researchers establish partnerships, little thought is given to regulatory ramifications of that partnership and thus finding themselves frustrated at the thought of having to provide additional information, gather additional signatures, and explain this regulatory requirement to their partners. Attending this webinar will provide you with information that can be passed along to partners to better explain the process. Why should you attend: Most investigators do not think about additional regulatory criteria when designing a study. The current trend is conduct research in private physician offices and other community venues. Although this makes research more accessible to potential participants, it also invokes another set of regulations and requirements. The one that many investigators and their potential research partners struggle with are the written agreements required by the institutional review board (IRB), namely the individual investigator agreement (IIA), IRB authorization agreement (IAA), and the Federalwide Assurance (FWA). The terms of these agreements can appear to be legalistic and intimidate both researchers and potential community partners. What are these? When are the necessary? Why are they necessary? Are all questions that will be answered during this webinar.Areas Covered in the Session:Federal wide AssuranceIndividual Investigator AgreementIRB Authorization AgreementWhen these agreements are used.Why these agreements are used.The process for establishing these agreementsAre there other types of agreements that institutions may enter into and how those would meet the regulatory framework.Who Will Benefit:Principal Investigators / Sub-investigatorsClinical Research Scientists (PKs, Biostatisticians,)Safety NursesClinical Research Associates (CRAs) and Coordinators (CRCs)Recruiting StaffQA / QC auditors and StaffClinical Research Data ManagersHuman Research Protection Professionals

When

13 Oct 2015 @ 10:00 am

13 Oct 2015 @ 11:00 am

Duration: 1 hours

Timezone: GMT -8:00


Where

Online Webinar


Language

Englishen


Organised by

NetZealous (deactivated)

Premium Events in Science

Other Events in Science

IAPD 2021

Netherlands, 9 Jun 2021

Similar Webinars in Science

Recent Publications in Science

Recent Videos in Science

Recent Speakers in Science

Alex Bloom
Consultant

1

Angus Silver
Speaker

1

Sponsors in Science

Recent News in Science

Today we are joining humanitarians & experts from across the 🌍 at the virtual 𝙃π™ͺπ™’π™–π™£π™žπ™©π™–π™§π™žπ™–π™£ π™‰π™šπ™©π™¬π™€π™§π™ π™¨ & π™‹π™–π™§π™©π™£π™šπ™§π™¨π™π™žπ™₯𝙨… https://t.co/5eeo8OwSRZ

@EU_ScienceHub - 21 Apr 2021 09:05

microMesh is a microscopic polymeric network to attack glioblastoma multiforme with nanomedicine

@https://erc.europa.eu/content/micromesh-microscopic-polymeric-network-attack-glioblastoma-multiforme-nanomedicine - 20 Apr 2021 14:47

microMesh is a microscopic polymeric network to attack glioblastoma multiforme with nanomedicine

@https://erc.europa.eu/content/micromesh-microscopic-polymeric-network-attack-glioblastoma-multiforme-nanomedicine - 20 Apr 2021 14:47

Premium EventsLearn more ..